Abilita Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Abilita Therapeutics General Information

Description

Developer of a membrane protein drug discovery platform designed to enable the development of therapeutics against challenging drug targets. The company's platform offers directed evolution-based stabilization of GPCRs, ion channels, and transporters; control of specific protein conformational states; and artificial intelligence (AI) and machine learning analysis of proprietary datasets, enabling biotechnology and pharmaceutical companies to discover antibody and small-molecule therapeutics against difficult membrane protein targets.

Contact Information

Formerly Known As
Abilita Bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5785 Oberlin Drive
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Pharmaceuticals
Vertical(s)
Corporate Office
  • 5785 Oberlin Drive
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abilita Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator Completed Pre-Clinical Trials
5. Early Stage VC (Series 1) 09-Dec-2022 Completed Pre-Clinical Trials
4. Grant 15-Sep-2021 Completed Product Development
3. Grant 20-Sep-2016 Completed Product Development
2. Accelerator/Incubator 01-Jan-2015 Completed Product Development
1. Angel (individual) 01-Jan-2015 Completed Product Development
To view Abilita Therapeutics’s complete valuation and funding history, request access »

Abilita Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed-1 177,788 $0.000010 8% $1.49 $1.49 1x $1.49 2.29%
Seed 2,114,462 $0.000010 8% $3.55 $3.55 1x $3.55 19.76%
To view Abilita Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Abilita Therapeutics Patents

Abilita Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024262910-A1 Anti-ccr8 antibodies, conjugates, and uses thereof Pending 28-Apr-2023
EP-4705346-A2 Anti-ccr8 antibodies, conjugates, and uses thereof Pending 28-Apr-2023
US-20250092146-A1 Anti-ccr8 antibodies, conjugates, and uses thereof Pending 28-Apr-2023
WO-2024227083-A2 Anti-ccr8 antibodies, conjugates, and uses thereof Inactive 28-Apr-2023
WO-2024227083-A3 Anti-ccr8 antibodies, conjugates, and uses thereof Inactive 28-Apr-2023 C07K16/2866
To view Abilita Therapeutics’s complete patent history, request access »

Abilita Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abilita Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Two Bear Capital Venture Capital Minority
U.S. Department of Health and Human Services Government
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
CONNECT (San Diego) Accelerator/Incubator
To view Abilita Therapeutics’s complete investors history, request access »

Abilita Therapeutics FAQs

  • When was Abilita Therapeutics founded?

    Abilita Therapeutics was founded in 2014.

  • Where is Abilita Therapeutics headquartered?

    Abilita Therapeutics is headquartered in San Diego, CA.

  • What is the size of Abilita Therapeutics?

    Abilita Therapeutics has 20 total employees.

  • What industry is Abilita Therapeutics in?

    Abilita Therapeutics’s primary industry is Drug Discovery.

  • Is Abilita Therapeutics a private or public company?

    Abilita Therapeutics is a Private company.

  • What is Abilita Therapeutics’s current revenue?

    The current revenue for Abilita Therapeutics is .

  • How much funding has Abilita Therapeutics raised over time?

    Abilita Therapeutics has raised $7.5M.

  • Who are Abilita Therapeutics’s investors?

    Two Bear Capital, U.S. Department of Health and Human Services, Johnson & Johnson Innovation - JLABS, and CONNECT (San Diego) have invested in Abilita Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process